FindTrial
Sign In

Homogenization Approaches for Improved Hyperkalemia Treatment in Clinical Practice: Outcomes and Disease Burden

Homogenization management of hyperkalemia throughout the hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116550
Enrollment
Unknown
Registered
2026-01-12
Start date
2025-12-05
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperkalemia

Interventions

Hyperkalemia Routine Group:none.
Hyperkalemia Homogeneous Group:none

Sponsors

Shanxi Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Serum potassium level > 5.0 mmol/L during hospitalization. 2. Life expectancy > 3 months.

Exclusion criteria

Exclusion criteria: 1. Life expectancy< 3 months; 2. Deemed ineligible for enrollment by other investigators.

Design outcomes

Primary

MeasureTime frame
hospitalization expenses;hospital stays;—

Secondary

MeasureTime frame
diagnosis rate;treatment rate;review rate;—

Countries

China

Contacts

Public ContactXiaoshuang Zhou

Shanxi Provincial People's Hospital

xiaoshuangzhou69@163.com+86 134 8531 8729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 4, 2026